> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-029.md).
# BRE 029
## Environmental EMF, Melatonin, Circadian Signaling, and Breast Cancer Risk
**Clinical Cancer Name:** Breast Carcinoma
**Common Cancer Name:** Breast Cancer
## Source
Brainard, G. C., Kavet, R., & Kheifets, L. I. (1999).
*The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of the relevant literature.*
*Journal of Pineal Research, 26, 65–100.*
***
## BRS Score
**BRS:** 6.6 / 10\
**STEMD:** S7 / T5 / E6 / M5 / D7\
**External Evidence Level:** Low–Moderate review-supported epidemiologic and circadian-hypothesis evidence
## Score Interpretation
BRE-029 receives a lower BRS than experimental treatment entries because it does not test TTFields, therapeutic EMF, or cancer-cell response. Its value is cautionary and conceptual. It helps BREXAtlas separate environmental exposure-risk hypotheses from controlled therapeutic electromagnetic intervention research.
***
## Entry Summary
BRE-029 asks a public-health and biology question:
Could environmental electromagnetic exposure affect melatonin or circadian signaling in ways that relate to breast cancer risk?
This review examined literature connecting electromagnetic-field exposure, light exposure, melatonin regulation, circadian biology, and breast cancer risk.
In simple language:
Melatonin is a hormone connected to sleep, light, circadian rhythm, and biological timing. Some researchers have asked whether environmental exposures could disturb melatonin and possibly relate to breast cancer risk.
BREXAtlas classifies this entry as a caution and ontology-separation entry, not a treatment entry.
***
## What BREXAtlas Found
BREXAtlas identifies this primary chain:
Environmental EMF exposure\
↓\
Potential melatonin suppression\
↓\
Circadian-system alteration\
↓\
Hormonal signaling disruption\
↓\
Uncertain breast-cancer association
A secondary chain is:
Light + EMF environmental exposure\
↓\
Biologic rhythm perturbation\
↓\
Population-level epidemiologic variability\
↓\
Conflicting interpretation outcomes
The extracted conclusion is that environmental electromagnetic-field exposure has been hypothesized to alter melatonin signaling and circadian regulation, but evidence linking those effects to breast cancer risk remains inconsistent.
***
## Questions This BRE Helps Answer
What is melatonin?
Melatonin is a hormone involved in sleep-wake timing and circadian rhythm.
What BREXAtlas found:\
BRE-029 supports that melatonin disruption has been proposed as a possible pathway in environmental exposure and breast cancer risk discussions.
Does this paper prove EMF causes breast cancer?
What BREXAtlas found:\
No.
The evidence remains inconsistent, difficult to standardize, and tied to environmental exposure questions rather than controlled treatment studies.
Why is this entry included in BREXAtlas?
Because BREXAtlas must organize both supportive and cautionary evidence.
BRE-029 helps separate:
* environmental EMF exposure-risk literature
* circadian and melatonin hypotheses
* therapeutic EMF studies
* TTFields treatment studies
* diagnostic electromagnetic systems
This separation protects the encyclopedia from overclaiming.
***
## Study Classification
| Category | Classification |
| -------------------------------------- | ----------------------------------------------------------------------- |
| Study Type | Environmental EMF / melatonin epidemiology review |
| Tissue Category | Breast carcinoma; melatonin systems; environmental EMF epidemiology |
| Common Cancer Name | Breast cancer |
| Primary Focus | Environmental exposure, melatonin, circadian signaling, risk hypothesis |
| Direct Treatment Evidence | No |
| Direct TTFields Evidence | No |
| Direct Cancer-Cell Evidence | No |
| Evidence Type | Review-supported epidemiologic synthesis |
| Suitable for Risk / Caution Index | Yes |
| Suitable for Treatment Mechanism Index | No |
***
## Mechanisms / Methodological Concepts
**MEC-083: Melatonin-Regulation Disruption**
Environmental EMF exposure has been hypothesized to alter melatonin regulation.
**MEC-084: Circadian-System Perturbation**
Light and electromagnetic exposure questions may involve biological rhythm disruption.
**MEC-079: Environmental EMF Epidemiology**
This entry belongs to population-level environmental exposure research, not therapeutic intervention research.
**MEC-085: Hormonal-Signaling Uncertainty**
The connection between environmental EMF, melatonin signaling, and breast cancer remains uncertain.
**MEC-081: Epidemiologic Inconsistency**
Population-level findings remain variable and difficult to standardize.
***
## Discovery
**DISC-015: Bioelectric Systems Oncology**
BRE-029 contributes to Bioelectric Systems Oncology by showing why evidence categories must be separated.
It does not support therapeutic intervention claims.
Its discovery value is organizational:
Environmental exposure-risk studies and treatment-response studies must not be treated as the same evidence type.
***
## Connections to Other BRE Entries
**Connected to BRE-028**
BRE-028 reviewed environmental ELF-EMF exposure and breast cancer risk using meta-analysis.
BRE-029 adds melatonin and circadian-system hypotheses to that environmental-risk discussion.
**Connected to BRE-027**
BRE-027 focused on electromagnetic techniques for breast cancer detection.
BRE-029 is different because it focuses on environmental exposure and possible risk.
**Connected to BRE-025**
BRE-025 studied therapeutic EMF effects on breast tumor growth and vascularity.
BRE-029 should not be used to validate or refute BRE-025 because therapeutic intervention studies and environmental exposure-risk studies answer different questions.
**Connected to BRE-024**
BRE-024 studied ELF-EMF effects in T47D breast cancer cells.
BRE-029 is population-level and environmental, so it should remain separate from cell-level experimental response evidence.
***
## Research Gaps Identified
**RG-142: Melatonin Measurement Standardization Gap**
Future studies need standardized melatonin measurement methods.
**RG-143: Circadian Exposure Timing Gap**
More work is needed to distinguish light exposure, timing, sleep disruption, and EMF exposure.
**RG-144: Environmental EMF Exposure Normalization Gap**
Exposure level, source, duration, and frequency require clearer normalization.
**RG-145: Hormonal Mechanism Validation Gap**
More direct evidence is needed to determine whether environmental EMF meaningfully affects breast-cancer-related hormonal pathways.
**RG-146: Risk-Therapy Separation Gap**
Environmental risk hypotheses must remain separated from therapeutic electromagnetic intervention evidence.
***
## Scientific Caution
Environmental EMF epidemiology and melatonin-related hypotheses should remain separated from therapeutic electromagnetic-intervention studies and TTFields findings.
***
## Why This Entry Matters
For researchers, BRE-029 is important because it protects scientific boundaries.
For patients and families, the simple message is this:
This study is not about using electromagnetic fields to treat breast cancer. It is about whether environmental exposures might affect hormones or circadian rhythm in ways that could relate to risk.
Those are different questions.
***
## Entry Conclusion
BRE-029 is a cautionary environmental-risk entry in the BREXAtlas Encyclopedia.
It does not prove that EMF causes breast cancer.
It does not support therapeutic EMF claims.
It does not test TTFields.
Its value is that it teaches BREXAtlas to separate environmental exposure, circadian biology, melatonin hypotheses, and therapeutic bioelectric oncology.
The central question emerging from this entry is:
How can bioelectric oncology responsibly separate environmental exposure-risk hypotheses from controlled therapeutic electromagnetic research?
For BREXAtlas, BRE-029 matters because credibility depends on clear evidence boundaries.
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://www.brexatlas.org/bre-001/bre-029.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.